The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccines & Vaccination Market Research Report 2025
Synopsis
The global Vaccines & Vaccination market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Vaccines & Vaccination is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vaccines & Vaccination is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Vaccines & Vaccination in Baby Vaccine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Vaccines & Vaccination include Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med, CSL, Emergent BioSolutions and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vaccines & Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines & Vaccination.
Report Scope
The Vaccines & Vaccination market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccines & Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines & Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Segment by Type
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Segment by Application
Baby Vaccine
Adult Special Vaccine
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccines & Vaccination companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Vaccines & Vaccination market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Vaccines & Vaccination is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vaccines & Vaccination is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Vaccines & Vaccination in Baby Vaccine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Vaccines & Vaccination include Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med, CSL, Emergent BioSolutions and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vaccines & Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines & Vaccination.
Report Scope
The Vaccines & Vaccination market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccines & Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines & Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Segment by Type
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Segment by Application
Baby Vaccine
Adult Special Vaccine
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccines & Vaccination companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccines & Vaccination Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Subunit vaccines
1.2.3 Live attenuated vaccines
1.2.4 Conjugate vaccines
1.2.5 Inactivated vaccines
1.2.6 Recombinant vector vaccines
1.2.7 Toxoid vaccines
1.2.8 Synthetic vaccines
1.2.9 Dendritic cell vaccines
1.3 Market by Application
1.3.1 Global Vaccines & Vaccination Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Baby Vaccine
1.3.3 Adult Special Vaccine
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccines & Vaccination Market Perspective (2019-2030)
2.2 Vaccines & Vaccination Growth Trends by Region
2.2.1 Global Vaccines & Vaccination Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vaccines & Vaccination Historic Market Size by Region (2019-2024)
2.2.3 Vaccines & Vaccination Forecasted Market Size by Region (2025-2030)
2.3 Vaccines & Vaccination Market Dynamics
2.3.1 Vaccines & Vaccination Industry Trends
2.3.2 Vaccines & Vaccination Market Drivers
2.3.3 Vaccines & Vaccination Market Challenges
2.3.4 Vaccines & Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccines & Vaccination Players by Revenue
3.1.1 Global Top Vaccines & Vaccination Players by Revenue (2019-2024)
3.1.2 Global Vaccines & Vaccination Revenue Market Share by Players (2019-2024)
3.2 Global Vaccines & Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccines & Vaccination Revenue
3.4 Global Vaccines & Vaccination Market Concentration Ratio
3.4.1 Global Vaccines & Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccines & Vaccination Revenue in 2023
3.5 Vaccines & Vaccination Key Players Head office and Area Served
3.6 Key Players Vaccines & Vaccination Product Solution and Service
3.7 Date of Enter into Vaccines & Vaccination Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccines & Vaccination Breakdown Data by Type
4.1 Global Vaccines & Vaccination Historic Market Size by Type (2019-2024)
4.2 Global Vaccines & Vaccination Forecasted Market Size by Type (2025-2030)
5 Vaccines & Vaccination Breakdown Data by Application
5.1 Global Vaccines & Vaccination Historic Market Size by Application (2019-2024)
5.2 Global Vaccines & Vaccination Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vaccines & Vaccination Market Size (2019-2030)
6.2 North America Vaccines & Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Vaccines & Vaccination Market Size by Country (2019-2024)
6.4 North America Vaccines & Vaccination Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccines & Vaccination Market Size (2019-2030)
7.2 Europe Vaccines & Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Vaccines & Vaccination Market Size by Country (2019-2024)
7.4 Europe Vaccines & Vaccination Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccines & Vaccination Market Size (2019-2030)
8.2 Asia-Pacific Vaccines & Vaccination Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Vaccines & Vaccination Market Size by Region (2019-2024)
8.4 Asia-Pacific Vaccines & Vaccination Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccines & Vaccination Market Size (2019-2030)
9.2 Latin America Vaccines & Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Vaccines & Vaccination Market Size by Country (2019-2024)
9.4 Latin America Vaccines & Vaccination Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccines & Vaccination Market Size (2019-2030)
10.2 Middle East & Africa Vaccines & Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Vaccines & Vaccination Market Size by Country (2019-2024)
10.4 Middle East & Africa Vaccines & Vaccination Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Vaccines & Vaccination Introduction
11.1.4 Abbott Revenue in Vaccines & Vaccination Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Vaccines & Vaccination Introduction
11.2.4 AstraZeneca Revenue in Vaccines & Vaccination Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Bavarian Nordic
11.3.1 Bavarian Nordic Company Detail
11.3.2 Bavarian Nordic Business Overview
11.3.3 Bavarian Nordic Vaccines & Vaccination Introduction
11.3.4 Bavarian Nordic Revenue in Vaccines & Vaccination Business (2019-2024)
11.3.5 Bavarian Nordic Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Vaccines & Vaccination Introduction
11.4.4 Novartis Revenue in Vaccines & Vaccination Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Bharat Biotech
11.5.1 Bharat Biotech Company Detail
11.5.2 Bharat Biotech Business Overview
11.5.3 Bharat Biotech Vaccines & Vaccination Introduction
11.5.4 Bharat Biotech Revenue in Vaccines & Vaccination Business (2019-2024)
11.5.5 Bharat Biotech Recent Development
11.6 Bio-Med
11.6.1 Bio-Med Company Detail
11.6.2 Bio-Med Business Overview
11.6.3 Bio-Med Vaccines & Vaccination Introduction
11.6.4 Bio-Med Revenue in Vaccines & Vaccination Business (2019-2024)
11.6.5 Bio-Med Recent Development
11.7 CSL
11.7.1 CSL Company Detail
11.7.2 CSL Business Overview
11.7.3 CSL Vaccines & Vaccination Introduction
11.7.4 CSL Revenue in Vaccines & Vaccination Business (2019-2024)
11.7.5 CSL Recent Development
11.8 Emergent BioSolutions
11.8.1 Emergent BioSolutions Company Detail
11.8.2 Emergent BioSolutions Business Overview
11.8.3 Emergent BioSolutions Vaccines & Vaccination Introduction
11.8.4 Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2019-2024)
11.8.5 Emergent BioSolutions Recent Development
11.9 GSK
11.9.1 GSK Company Detail
11.9.2 GSK Business Overview
11.9.3 GSK Vaccines & Vaccination Introduction
11.9.4 GSK Revenue in Vaccines & Vaccination Business (2019-2024)
11.9.5 GSK Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Vaccines & Vaccination Introduction
11.10.4 Johnson & Johnson Revenue in Vaccines & Vaccination Business (2019-2024)
11.10.5 Johnson & Johnson Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Vaccines & Vaccination Introduction
11.11.4 Pfizer Revenue in Vaccines & Vaccination Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Vaccines & Vaccination Introduction
11.12.4 Merck Revenue in Vaccines & Vaccination Business (2019-2024)
11.12.5 Merck Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Vaccines & Vaccination Introduction
11.13.4 Sanofi Revenue in Vaccines & Vaccination Business (2019-2024)
11.13.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
